Healthpeak Properties (DOC) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Healthpeak Properties · Real Estate · ref. ETF XLRE · 50 calls · price $21.22
What the company does: Healthpeak Properties, Inc. is a Standard & Poor's 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States.
📈 Healthpeak Properties (DOC) stock price
$21.22+18.8% over range
Aug 28, 25low $15.78 · high $22.82Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
33% recommend buying · 12 analysts
📊 JPI status : Healthpeak Properties has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 DOC price target & analyst consensus — price $21.22
The price target · all analysts combined (12 targets)
Highest target · 4 firms of 12$24+13.1%
Median target · of 12 targets$22.5+6.0%
Lowest target · 2 firms of 12$21-1.0%
Current price$21.22
Where these 12 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1083%
$21.50 ↔ $24
Below
217%
$21
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Cantor Fitzgerald — 77% of its targets hit on this sector (13 calls tested). It aims for $23 (+8.4 %), call made on August 7, 2026, maturing on August 7, 2027 (21 d ago).
The 4 reliable analysts
$22.50+6.1 %
The 8 other firms
$22.50+6.0 %
How to read it: the 4 reliable firms are not filtered by optimism — 3 aim above the price, 1 below, hence their $22.50 median. “The 8 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 12 ratings (last 6 months)
Strong Buy00%
Buy433%
Hold867%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 DOC price target all
All 12 calls, one by one, with our verdict on each firm.
→ See all 12 targets, analyst by analyst💡 The best analysts on DOC most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in DOC? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Healthpeak Properties? The JPI assistant answers using our backtest data.
💰 Healthpeak Properties dividend: yield, history & growth › open the full page
5.66%annual yield
That's ~$1.22 per share per year.
📈 Healthpeak Properties fundamentals: valuation, margins & growth › open the full page
P/E 62.4Net margin 8.2 %Revenue growth +11.1 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 24 %
2023
Rev +6%Profit −39%
2024
Rev +23%Profit −20%
2025
Rev +4%Profit −71%
🔎 Detailed analyses
✅ Historical analyst reliability on DOC
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| B of A Securities ↗ | 100% | +8.4% | 2 |
| JP Morgan ↗ | 50% | +5.3% | 2 |
| Wells Fargo ↗ | 50% | +4.5% | 2 |
| Scotiabank ↗ | 40% | +0.9% | 5 |
| Baird ↗ | 25% | -4.3% | 4 |
| Mizuho ↗ | 20% | -1.8% | 5 |
| Wedbush ↗ | 0% | -12.3% | 5 |
| RBC Capital ↗ | 0% | -19.6% | 6 |
| Evercore ISI Group ↗ | 0% | -22.5% | 2 |
| Barclays ↗ | 0% | -22.6% | 3 |
📊 What $1,000 invested in Healthpeak Properties would be worth › open the full page
In short — $1,000 invested in Healthpeak Properties 10 years ago would be worth $654 today, i.e. -4%/yr on average. Best year: 2018 (+31%), worst: 2023 (-33%). Price performance, excluding dividends.
If I'd invested $1,000 in Healthpeak Properties
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,036 | +4% |
| 3 years ago | $779 | -22% |
| 5 years ago | $722 | -28% |
Return by year (Healthpeak Properties)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +24% | $1,241 (+24%) |
| 2025 | -17% | $1,036 (+4%) |
| 2024 | +12% | $1,157 (+16%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Healthpeak Properties
Loading news…
📋 All analyst calls on DOC
Filtered on — · ✕ show all
▲ Outperform · 🎯$24
Price at call : $20.81 — upside +15%
Today : $21.22 — upside +13%
🎯 on DOC : 33% (3 calls matureds) · 📊 on Real estate : 48.6% · -1.1% (70 calls)
in progress (365j)
matures : Aug 13, 27
matures : Aug 13, 27
■ Neutral neutral · not a buy · 🎯$22
Price at call : $20.66 — gap to target +6%
Today : $21.22 — gap to target +4%
🎯 on DOC : no call matured yet · 📊 on Real estate : 56.7% · +4.9% (194 calls)
in progress (365j)
matures : Aug 11, 27
matures : Aug 11, 27
RBC Capital ↗
Aug 10, 26
▲ Outperform · 🎯$24
Price at call : $20.51 — upside +17%
Today : $21.22 — upside +13%
🎯 on DOC : 0% (1 call matured) · 📊 on Real estate : 46.1% · -0.6% (204 calls)
in progress (365j)
matures : Aug 10, 27
matures : Aug 10, 27
Cantor Fitzgerald ↗
Aug 6, 26
■ Neutral neutral · not a buy · 🎯$23
Price at call : $21.1 — gap to target +9%
Today : $21.22 — gap to target +8%
🎯 on DOC : no call matured yet · 📊 on Real estate : 69.2% · +12.3% (13 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
Wells Fargo ↗
Jul 15, 26
■ Equal-Weight neutral · not a buy · 🎯$22
Price at call : $21.74 — gap to target +1%
Today : $21.22 — gap to target +4%
🎯 on DOC : no call matured yet · 📊 on Real estate : 53.6% · +2.8% (237 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
■ Neutral neutral · not a buy · 🎯$21.5
Price at call : $21.57 — gap to target -0%
Today : $21.22 — gap to target +1%
🎯 on DOC : no call matured yet · 📊 on Real estate : 38.5% · -1.8% (96 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
■ Equal-Weight neutral · not a buy · 🎯$23
Price at call : $21.93 — gap to target +5%
Today : $21.22 — gap to target +8%
🎯 on DOC : no call matured yet · 📊 on Real estate : 40.3% · -1.2% (395 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
▲ Outperform · 🎯$24
Price at call : $21.75 — upside +10%
Today : $21.22 — upside +13%
🎯 on DOC : 0% (1 call matured) · 📊 on Real estate : 48.2% · +0.3% (170 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
See the other 42 calls, newest to oldest
■ Neutral neutral · not a buy · 🎯$21
Price at call : $21.23 — gap to target -1%
Today : $21.22 — gap to target -1%
🎯 on DOC : no call matured yet · 📊 on Real estate : 54.2% · +2.9% (168 calls)
in progress (365j)
matures : Jun 24, 27
matures : Jun 24, 27
BMO Capital ↗
Jun 15, 26
▲ Outperform · 🎯$24
Price at call : $20.09 — upside +19%
Today : $21.22 — upside +13%
🎯 on DOC : no call matured yet · 📊 on Real estate : 43.6% · -1.7% (101 calls)
in progress (365j)
matures : Jun 15, 27
matures : Jun 15, 27
Morgan Stanley ↗
Jun 11, 26
■ Equal-Weight neutral · not a buy · 🎯$22
Price at call : $20.69 — gap to target +6%
Today : $21.22 — gap to target +4%
🎯 on DOC : 100% (1 call matured) · 📊 on Real estate : 53.6% · +1.8% (224 calls)
in progress (365j)
matures : Jun 11, 27
matures : Jun 11, 27
Wells Fargo ↗
Jun 1, 26
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $19.45 — gap to target +3%
Today : $21.22 — gap to target -6%
🎯 on DOC : no call matured yet · 📊 on Real estate : 53.6% · +2.8% (237 calls)
in progress (365j)
matures : Jun 1, 27
matures : Jun 1, 27
Scotiabank ↗
May 27, 26
■ Sector Perform neutral · not a buy · 🎯$21
Price at call : $19.51 — gap to target +8%
Today : $21.22 — gap to target -1%
🎯 on DOC : 50% (2 calls matureds) · 📊 on Real estate : 37.2% · -0.1% (78 calls)
in progress (365j)
matures : May 27, 27
matures : May 27, 27
Morgan Stanley ↗
May 22, 26
▲ Overweight · 🎯$20
Price at call : $20.03 — upside -0%
Today : $21.22 — upside -6%
🎯 on DOC : 100% (1 call matured) · 📊 on Real estate : 53.6% · +1.8% (224 calls)
in progress (365j)
matures : May 22, 27
matures : May 22, 27
RBC Capital ↗
May 14, 26
▲ Outperform · 🎯$21
Price at call : $19.36 — upside +8%
Today : $21.22 — upside -1%
🎯 on DOC : 0% (1 call matured) · 📊 on Real estate : 46.1% · -0.6% (204 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
■ Neutral neutral · not a buy · 🎯$19
Price at call : $19.56 — gap to target -3%
Today : $21.22 — gap to target -10%
🎯 on DOC : no call matured yet · 📊 on Real estate : 38.5% · -1.8% (96 calls)
in progress (365j)
matures : May 13, 27
matures : May 13, 27
▲ Outperform · 🎯$21
Price at call : $19.55 — upside +7%
Today : $21.22 — upside -1%
🎯 on DOC : 33% (3 calls matureds) · 📊 on Real estate : 48.6% · -1.1% (70 calls)
in progress (365j)
matures : May 13, 27
matures : May 13, 27
■ Neutral neutral · not a buy · 🎯$20
Price at call : $19.55 — gap to target +2%
Today : $21.22 — gap to target -6%
🎯 on DOC : no call matured yet · 📊 on Real estate : 56.7% · +4.9% (194 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
Morgan Stanley ↗
Apr 28, 26
▲ Overweight · 🎯$18
Price at call : $15.99 — upside +13%
Today : $21.22 — upside -15%
🎯 on DOC : 100% (1 call matured) · 📊 on Real estate : 53.6% · +1.8% (224 calls)
in progress (365j)
matures : Apr 28, 27
matures : Apr 28, 27
■ Neutral neutral · not a buy · 🎯$17
Price at call : $16.47 — gap to target +3%
Today : $21.22 — gap to target -20%
🎯 on DOC : no call matured yet · 📊 on Real estate : 38.5% · -1.8% (96 calls)
in progress (365j)
matures : Apr 20, 27
matures : Apr 20, 27
▲ Outperform · 🎯$19
Price at call : $16.67 — upside +14%
Today : $21.22 — upside -10%
🎯 on DOC : 33% (3 calls matureds) · 📊 on Real estate : 48.6% · -1.1% (70 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
■ Neutral neutral · not a buy · 🎯$17.5
Price at call : $16.52 — gap to target +6%
Today : $21.22 — gap to target -18%
🎯 on DOC : no call matured yet · 📊 on Real estate : 56.7% · +4.9% (194 calls)
in progress (365j)
matures : Apr 1, 27
matures : Apr 1, 27
Argus Research ↗
Feb 5, 26
■ Hold neutral · not a buy
🎯 on DOC : 0% (1 call matured) · 📊 on Real estate : 46.4% · +1.8% (56 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
Evercore ISI Group ↗
Feb 4, 26
▲ Outperform · 🎯$19
Price at call : $16.68 — upside +14%
Today : $21.22 — upside -10%
🎯 on DOC : 0% (1 call matured) · 📊 on Real estate : 47.3% · +1.2% (150 calls)
in progress (365j)
matures : Feb 4, 27
matures : Feb 4, 27
Wells Fargo ↗
Feb 2, 26
■ Equal-Weight neutral · not a buy · 🎯$18
Price at call : $16.45 — gap to target +9%
Today : $21.22 — gap to target -15%
🎯 on DOC : no call matured yet · 📊 on Real estate : 53.6% · +2.8% (237 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
Goldman Sachs ↗
Jan 9, 26
■ Neutral neutral · not a buy · 🎯$17
Price at call : $16.71 — gap to target +2%
Today : $21.22 — gap to target -20%
🎯 on DOC : no call matured yet · 📊 on Real estate : 54.4% · +3.7% (103 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
■ Hold neutral · not a buy · 🎯$17
Price at call : $16.36 — gap to target +4%
Today : $21.22 — gap to target -20%
🎯 on DOC : no call matured yet · 📊 on Real estate : 51.6% · +2.3% (128 calls)
in progress (365j)
matures : Dec 16, 26
matures : Dec 16, 26
Evercore ISI Group ↗
Dec 15, 25
▲ Outperform · 🎯$21
Price at call : $16.36 — upside +28%
Today : $21.22 — upside -1%
🎯 on DOC : 0% (1 call matured) · 📊 on Real estate : 47.3% · +1.2% (150 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
Wells Fargo ↗
Nov 25, 25
■ Equal-Weight neutral · not a buy · 🎯$19
Price at call : $18.22 — gap to target +4%
Today : $21.22 — gap to target -10%
🎯 on DOC : no call matured yet · 📊 on Real estate : 53.6% · +2.8% (237 calls)
in progress (365j)
matures : Nov 25, 26
matures : Nov 25, 26
▲ Outperform · 🎯$20
Price at call : $17.51 — upside +14%
Today : $21.22 — upside -6%
🎯 on DOC : 33% (3 calls matureds) · 📊 on Real estate : 48.6% · -1.1% (70 calls)
in progress (365j)
matures : Nov 12, 26
matures : Nov 12, 26
Cantor Fitzgerald ↗
Oct 1, 25
■ Neutral neutral · not a buy · 🎯$20
Price at call : $19.18 — gap to target +4%
Today : $21.22 — gap to target -6%
🎯 on DOC : no call matured yet · 📊 on Real estate : 69.2% · +12.3% (13 calls)
in progress (365j)
matures : Oct 1, 26
matures : Oct 1, 26
Raymond James ↗
Sep 15, 25
▲ Outperform · 🎯$20
Price at call : $18.25 — upside +10%
Today : $21.22 — upside -6%
🎯 on DOC : no call matured yet · 📊 on Real estate : 51.9% · +2.1% (270 calls)
in progress (365j)
matures : Sep 15, 26
matures : Sep 15, 26
Wells Fargo ↗
Aug 27, 25
■ Equal-Weight neutral · not a buy · 🎯$18
Price at call : $17.86 — gap to target +1%
Today : $21.22 — gap to target -15%
🎯 on DOC : no call matured yet · 📊 on Real estate : 53.6% · +2.8% (237 calls)
in progress (365j)
matures : Aug 27, 26
matures : Aug 27, 26
Morgan Stanley ↗
Aug 22, 25
▲ Overweight · 🎯$21
Price at call : $17.65 — upside +19%
Today : $21.22 — upside -1%
Expected +19% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on DOC : 100% (1 call matured) · 📊 on Real estate : 53.6% · +1.8% (224 calls)
+22.6%
stock +23% · XLRE +8%
matured Aug 22, 26
Deutsche Bank ↗
Aug 20, 25
■ Hold neutral · not a buy · 🎯$18
Price at call : $17.22 — gap to target +5%
Today : $21.22 — gap to target -15%
🎯 on DOC : no call matured yet · 📊 on Real estate : 62.4% · +8.3% (194 calls)
in progress (365j)
matures : Aug 20, 26
matures : Aug 20, 26
▲ Outperform · 🎯$21
Price at call : $16.94 — upside +24%
Today : $21.22 — upside -1%
Expected +24% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on DOC : 33% (3 calls matureds) · 📊 on Real estate : 48.6% · -1.1% (70 calls)
+28.9%
stock +29% · XLRE +9%
matured Jul 30, 26
Scotiabank ↗
Jul 29, 25
■ Sector Perform neutral · not a buy · 🎯$19
Price at call : $17.37 — gap to target +9%
Today : $21.22 — gap to target -10%
🎯 on DOC : 50% (2 calls matureds) · 📊 on Real estate : 37.2% · -0.1% (78 calls)
in progress (365j)
matures : Jul 29, 26
matures : Jul 29, 26
Wells Fargo ↗
Jun 2, 25
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $17.15 — gap to target +17%
Today : $21.22 — gap to target -6%
🎯 on DOC : no call matured yet · 📊 on Real estate : 53.6% · +2.8% (237 calls)
in progress (365j)
matures : Jun 2, 26
matures : Jun 2, 26
Scotiabank ↗
May 12, 25
▲ Sector Outperform · 🎯$21
Price at call : $17.25 — upside +22%
Today : $21.22 — upside -1%
Expected +22% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on DOC : 50% (2 calls matureds) · 📊 on Real estate : 37.2% · -0.1% (78 calls)
+13.3%
stock +13% · XLRE +8%
matured May 12, 26
Argus Research ↗
Apr 29, 25
▲ Buy · 🎯$25
Price at call : $17.84 — upside +40%
Today : $21.22 — upside +18%
Expected +40% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on DOC : 0% (1 call matured) · 📊 on Real estate : 46.4% · +1.8% (56 calls)
-9.4%
stock -9% · XLRE +8%
matured Apr 29, 26
▲ Outperform · 🎯$22
Price at call : $17.76 — upside +24%
Today : $21.22 — upside +4%
Expected +24% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on DOC : 33% (3 calls matureds) · 📊 on Real estate : 48.6% · -1.1% (70 calls)
-10.0%
stock -10% · XLRE +6%
matured Apr 29, 26
Evercore ISI Group ↗
Apr 28, 25
▲ Outperform · 🎯$21
Price at call : $17.76 — upside +18%
Today : $21.22 — upside -1%
Expected +18% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on DOC : 0% (1 call matured) · 📊 on Real estate : 47.3% · +1.2% (150 calls)
-10.0%
stock -10% · XLRE +6%
matured Apr 28, 26
▲ Outperform · 🎯$22
Price at call : $17.75 — upside +24%
Today : $21.22 — upside +4%
Expected +24% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on DOC : 0% (3 calls matureds) · 📊 on Real estate : 36.7% · -2.5% (30 calls)
-9.6%
stock -10% · XLRE +8%
matured Apr 28, 26
▲ Outperform · 🎯$24
Price at call : $18.71 — upside +28%
Today : $21.22 — upside +13%
Expected +28% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on DOC : 0% (3 calls matureds) · 📊 on Real estate : 36.7% · -2.5% (30 calls)
-11.8%
stock -12% · XLRE +8%
matured Apr 11, 26
Scotiabank ↗
Mar 1, 25
▲ Sector Outperform · 🎯$23
Price at call : $20.4 — upside +13%
Today : $21.22 — upside +8%
Expected +13% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on DOC : 50% (2 calls matureds) · 📊 on Real estate : 37.2% · -0.1% (78 calls)
-13.6%
stock -14% · XLRE +1%
matured Mar 1, 26
▲ Outperform · 🎯$24
Price at call : $19.58 — upside +23%
Today : $21.22 — upside +13%
Expected +23% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on DOC : 0% (3 calls matureds) · 📊 on Real estate : 36.7% · -2.5% (30 calls)
-12.0%
stock -12% · XLRE +4%
matured Feb 14, 26
▲ Outperform · 🎯$24
Price at call : $19.61 — upside +22%
Today : $21.22 — upside +13%
Expected +22% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on DOC : 33% (3 calls matureds) · 📊 on Real estate : 48.6% · -1.1% (70 calls)
-13.5%
stock -14% · XLRE +1%
matured Feb 11, 26
Wells Fargo ↗
Dec 10, 24
■ Equal-Weight neutral · not a buy · 🎯$22
Price at call : $21.27 — gap to target +3%
Today : $21.22 — gap to target +4%
🎯 on DOC : no call matured yet · 📊 on Real estate : 53.6% · +2.8% (237 calls)
in progress (365j)
matures : Dec 10, 25
matures : Dec 10, 25
▲ Outperform · 🎯$24
Price at call : $21.49 — upside +12%
Today : $21.22 — upside +13%
Expected +12% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on DOC : 0% (1 call matured) · 📊 on Real estate : 48.2% · +0.3% (170 calls)
-20.8%
stock -21% · XLRE -6%
matured Dec 5, 25
RBC Capital ↗
Nov 4, 24
▲ Outperform · 🎯$26
Price at call : $22.51 — upside +16%
Today : $21.22 — upside +23%
Expected +16% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on DOC : 0% (1 call matured) · 📊 on Real estate : 46.1% · -0.6% (204 calls)
-20.6%
stock -21% · XLRE -7%
matured Nov 4, 25
Frequently asked questions
Should I buy Healthpeak Properties stock?
This isn't buy advice. For Healthpeak Properties, the analyst consensus is "Hold", with an average price target of $22.50 (+6% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Healthpeak Properties). We show the numbers — you decide.
Is it too late to buy Healthpeak Properties? How high can it go?
The most bullish analyst target on Healthpeak Properties is $24.00 (+13% above today's price); the average is $22.50. That's the upside they see. Check how reliable those analysts have actually been on Healthpeak Properties on our site before trusting it.
Is Healthpeak Properties still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 11 analysts have a real record on Healthpeak Properties, the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.
Should you invest in Healthpeak Properties? The case for and against
The arguments for and against, one by one, from the numbers: why invest in DOC (and why hesitate).
What has Healthpeak Properties's past performance been?
Historical returns and a "how much if I had invested" calculator: DOC performance & returns.
Does Healthpeak Properties pay a dividend?
Yield, consistency and growth history of the dividend: DOC's dividend.
ESS 
EQIX 
AVB 
AMT 
EQR 
DLR 
BXP 
SBAC